Bridgette Collins-Burow, MD, PhD

Return to Tulane Doctors

Dr. Collins-Burow received her B.S. in Chemistry in 1994 from the University of Southern Mississippi. She completed her Ph.D. research in 1998 at Tulane University from the Interdisciplinary Graduate Program in Molecular and Cellular Biology. Dr. Collins-Burow went on to Medical School at Tulane University where she matriculated in 2002.  Dr. Collins-Burow completed her Internal Medicine Residency in 2005 and her Hematology/Oncology Fellowship in 2008 both at Tulane University School of Medicine in New Orleans, Louisiana. 

In July 2008, Dr. Collins-Burow joined Tulane University School of Medicine, Department of Medicine, Section of Hematology/Oncology as an Assistant Professor of Medicine.

Dr. Collins-Burow's research program combines investigator initiated proof-of principle clinical trials with solid basic-translational bench research. Dr. Collins-Burow’s research focuses on the role of novel experimental agents and epigenetic therapy in the regulation of microRNA expression in breast cancer with specific interest in triple-negative or basal phenotype breast cancer.